These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 7433469)
1. Content uniformity of tablets--a comparison of data from automated analysis of tablets performed by two different laboratories. Waaler T; Gundersen H; Kvaleid I; Torud Y; Müller H; Hasler C Pharm Acta Helv; 1980; 55(7-8):203-9. PubMed ID: 7433469 [No Abstract] [Full Text] [Related]
2. Development and validation of a fully automated method for the chromatographic determination of content uniformity of drug tablets. Toro I; Dulsat JF; Fábregas JL; Claramunt J J Pharm Biomed Anal; 2004 Sep; 36(1):57-63. PubMed ID: 15351048 [TBL] [Abstract][Full Text] [Related]
3. [Study of the statistical characteristics of the USP XXI content uniformity sampling plan for tablets]. Tao QF; Zhong DF; Luo X; Wang X Yao Xue Xue Bao; 1987 Mar; 22(3):212-6. PubMed ID: 3661209 [No Abstract] [Full Text] [Related]
4. Semiautomated method for analysis of nitroglycerin in sublingual tablets: collaborative study. Juhl YH J Assoc Off Anal Chem; 1980 Jul; 63(4):696-701. PubMed ID: 6772623 [TBL] [Abstract][Full Text] [Related]
5. Statistical analysis of the USP 18 content uniformity sampling plan for tablets. Langenbucher F Pharm Acta Helv; 1972; 47(2):142-52. PubMed ID: 5024143 [No Abstract] [Full Text] [Related]
7. Calculation of data from automated systems of analysis. Torud Y Pharm Acta Helv; 1971 Apr; 46(4):248-56. PubMed ID: 5575013 [No Abstract] [Full Text] [Related]
8. Content uniformity of potent drugs in tablets. Orr NA; Sallam EA J Pharm Pharmacol; 1978 Dec; 30(12):741-7. PubMed ID: 32236 [TBL] [Abstract][Full Text] [Related]
9. The effect of the analytical error on content uniformity sampling plans. Norberg R Pharm Acta Helv; 1972; 47(11):710-8. PubMed ID: 4657537 [No Abstract] [Full Text] [Related]
10. [Studies on a new sampling scheme by variables for the content uniformity of tablets]. Zhong DF; Wang X; Luo X Yao Xue Xue Bao; 1986 Feb; 21(2):130-6. PubMed ID: 3751592 [No Abstract] [Full Text] [Related]
11. Automated fluorometric analysis of reserpine and syrosingopine tablets, using a vanadium pentoxide reagent. Urbányi T; Stober H J Assoc Off Anal Chem; 1972 Jan; 55(1):180-4. PubMed ID: 4147179 [No Abstract] [Full Text] [Related]
12. Content uniformity and assay requirements in current regulations. Bánfai B; Ganzler K; Kemény S J Chromatogr A; 2007 Jul; 1156(1-2):206-12. PubMed ID: 17109871 [TBL] [Abstract][Full Text] [Related]
13. International harmonization of generic drugs: in vitro dissolution tests for Japanese and American generic tablets. Otsuka M; Tomita H; Otsuka K; Kamae I; Jorgenson JA Biomed Mater Eng; 2006; 16(2):129-35. PubMed ID: 16477121 [TBL] [Abstract][Full Text] [Related]
14. Uniformity of content requirements for tablets and capsules. Kendall CE; Low GK; Hailey DM J Pharm Pharmacol; 1981 Apr; 33(4):197-202. PubMed ID: 6115899 [TBL] [Abstract][Full Text] [Related]
15. Construction and operation of an automated dispensing analyzer for the assay of individual tablets. Beyer WF; Smith EW J Pharm Sci; 1970 Feb; 59(2):248-53. PubMed ID: 5411349 [No Abstract] [Full Text] [Related]
16. Applications of NIR in early stage formulation development. Part II. Content uniformity evaluation of low dose tablets by principal component analysis. Li W; Bagnol L; Berman M; Chiarella RA; Gerber M Int J Pharm; 2009 Oct; 380(1-2):49-54. PubMed ID: 19576977 [TBL] [Abstract][Full Text] [Related]
17. Automated analysis of nitroglycerin in tablets. Waaler T; Gundersen H; Kvaleid I; Shangraw R Pharm Acta Helv; 1977; 52(1-2):17-9. PubMed ID: 407581 [No Abstract] [Full Text] [Related]
18. On-line content uniformity determination of tablets using low-resolution Raman spectroscopy. Wikström H; Romero-Torres S; Wongweragiat S; Williams JA; Grant ER; Taylor LS Appl Spectrosc; 2006 Jun; 60(6):672-81. PubMed ID: 16808869 [TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of dried yeast tablets using different techniques. Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410 [TBL] [Abstract][Full Text] [Related]
20. The presence of microorganisms in some common excipients used in tablet formulation. Obuekwe IF; Eichie F Acta Pol Pharm; 2006; 63(2):121-5. PubMed ID: 17514875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]